Surrozen (SRZN) Research & Development (2020 - 2026)
Surrozen (SRZN) posted Research & Development of $8.48 million for Q2 2026, up 40.4% from $6.04 million a year earlier but down 9.0% from the prior quarter.
Powered by 
Analysis
Surrozen (SRZN) Research & Development (2020 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Research & Development at Surrozen was $34.58 million, up 49.4% year-over-year; for FY2025, it came in at $29.37 million, up 39.0% from FY2024.
- Annual Research & Development shows a five-year compound annual growth rate of 2.7% (FY2020 to FY2025).
- In prior years, Surrozen's Research & Development was $21.13 million in FY2024 (-22.4%), $27.23 million in FY2023 (-26.4%), $37.01 million in FY2022 (-7.9%) and $40.18 million in FY2021 (+56.4%).
- Quarterly Research & Development has run from a low of $5.2 million in Q3 2024 to a high of $10.89 million in Q4 2021 over five years.
- On a year-over-year basis, Research & Development has increased in each of the last six quarters, with growth averaging 26.4% over the last eight quarters.
- The strongest year-over-year quarter for Research & Development in the past five years was Q4 2025, with growth of 68.1%; the weakest was Q4 2023, with a decline of 35.4%.
- According to Business Quant data, Research & Development for the three prior quarters was $9.33 million (Q1 2026), $8.99 million (Q4 2025) and $7.77 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 3.65 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 2.34 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 9.74 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | -2.85 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -4.05 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 1.87 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 1.76 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 2.81 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 993.80 Mn |
| 10 | Surrozen | 348.39 Mn | 348.39 Mn | - | 8.48 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 8.48 Mn |
| Mar 31, 2026 | 9.33 Mn |
| Dec 31, 2025 | 8.99 Mn |
| Sep 30, 2025 | 7.77 Mn |
| Jun 30, 2025 | 6.04 Mn |
| Mar 31, 2025 | 6.56 Mn |
| Dec 31, 2024 | 5.35 Mn |
| Sep 30, 2024 | 5.20 Mn |
| Jun 30, 2024 | 5.34 Mn |
| Mar 31, 2024 | 5.25 Mn |
| Dec 31, 2023 | 6.10 Mn |
| Sep 30, 2023 | 6.11 Mn |
| Jun 30, 2023 | 6.94 Mn |
| Mar 31, 2023 | 8.09 Mn |
| Dec 31, 2022 | 9.44 Mn |
| Sep 30, 2022 | 8.62 Mn |
| Jun 30, 2022 | 9.58 Mn |
| Mar 31, 2022 | 9.37 Mn |
| Dec 31, 2021 | 10.89 Mn |
| Sep 30, 2021 | 10.42 Mn |
API Access
Surrozen Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=SRZN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "SRZN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=SRZN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();